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A temporally dynamic Foxp3 autoregulatory
transcriptional circuit controls the effector
Treg programme
David Bending1,† , Alina Paduraru1, Catherine B Ducker1, Paz Prieto Martín1, Tessa Crompton2 &
Masahiro Ono1,*
Abstract
Regulatory T cells (Treg) are negative regulators of the immune
response; however, it is poorly understood whether and how Foxp3
transcription is induced and regulated in the periphery during T-
cell responses. Using Foxp3-Timer of cell kinetics and activity
(Tocky) mice, which report real-time Foxp3 expression, we show
that the flux of new Foxp3 expressors and the rate of Foxp3 tran-
scription are increased during inflammation. These persistent
dynamics of Foxp3 transcription determine the effector Treg
programme and are dependent on a Foxp3 autoregulatory tran-
scriptional circuit. Persistent Foxp3 transcriptional activity controls
the expression of coinhibitory molecules, including CTLA-4 and
effector Treg signature genes. Using RNA-seq, we identify two
groups of surface proteins based on their relationship to the
temporal dynamics of Foxp3 transcription, and we show proof of
principle for the manipulation of Foxp3 dynamics by immunother-
apy: new Foxp3 flux is promoted by anti-TNFRII antibody, and
high-frequency Foxp3 expressors are targeted by anti-OX40 anti-
body. Collectively, our study dissects time-dependent mechanisms
behind Foxp3-driven T-cell regulation and establishes the Foxp3-
Tocky system as a tool to investigate the mechanisms behind T-cell
immunotherapies.
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Introduction
Upon antigen recognition through the T-cell receptor (TCR), T cells
express interleukin(IL)-2 and CD25 (IL-2 receptor alpha chain),
which together promote T-cell activation, proliferation, and
differentiation (Shimizu et al, 1986; Gaffen, 2001). Intriguingly,
CD25-expressing T cells from healthy animals are markedly enriched
with regulatory T cells (Treg) that express the transcription factor
Foxp3 (Fontenot et al, 2003; Hori et al, 2003). Foxp3 expression is a
major determinant of Treg phenotype and function, and Foxp3 inter-
acts with transcription factor complexes, such as those involving
NFAT and Runx1, to repress IL-2 transcription and convert the
effector mechanisms in T cells into a suppressive one (Wu et al,
2006; Ono et al, 2007; Rudra et al, 2012). Treg have activated
phenotypes, and upon TCR signals, Treg suppress the activities of
conventional T cells (Shevach, 2000). TCR signalling is the major
regulator of Treg differentiation in the thymus, as T cells that have
received strong TCR signals preferentially express CD25 and Foxp3
and differentiate into Treg (Hsieh et al, 2012). Additionally, costim-
ulatory receptors augment TCR signal-dependent Foxp3 and CD25
expression (Tai et al, 2005; Mahmud et al, 2014). In the periphery,
strong TCR signals further differentiate Treg into “effector Treg”,
showing enhanced suppressive function (Rosenblum et al, 2016).
Accumulating evidence indicates that Foxp3 expression is
dynamically controlled in Treg and non-Treg. TCR stimulation
induces Foxp3 expression in human (Tran et al, 2007) and mouse T
cells (Miyao et al, 2012) in vitro. Studies using T-cell receptor (TCR)
transgenic systems have shown that Foxp3 expression is induced in
non-Treg in some inflammatory conditions in vivo (Curotto de
Lafaille et al, 2008). Although such induced Foxp3 expression is
often dismissed as “transient expression”, the dynamic induction of
Foxp3 expression may have functional roles during T-cell responses
if this reactive Foxp3 expression occurs in activated polyclonal T
cells during inflammation in vivo (Ono & Tanaka, 2016). In addition,
Foxp3 expression can be dynamically downregulated in Treg. Fate-
mapping experiments showed that, while most of thymus-derived
Foxp3+ T cells stably express Foxp3, some Foxp3+ cells downregu-
late Foxp3 to become ex-Foxp3 cells in the periphery, joining the
memory-phenotype T-cell pool (Miyao et al, 2012). PD-1 KO mice
with a partial Foxp3 insufficiency lead to generation of ex-Foxp3
effector T cells (Zhang et al, 2016), indicating that the mechanism
of T-cell activation is involved in the dynamic regulation of Foxp3
transcription. These findings lead to the hypothesis that Foxp3 acts
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as a cell-intrinsic and transcellular negative feedback regulator for
T-cell activation among self-reactive T-cell repertoires (Ono &
Tanaka, 2016), challenging the thymus-central view of Treg-
mediated immune regulation.
The key question is whether and how frequently activation of
new Foxp3 transcription is induced in non-Treg cells in physiological
conditions, and how Foxp3 transcription is sustained in existing Treg
during the immune response. Since the death rate of Treg and other
T cells is difficult to determine experimentally, the relative propor-
tions of Foxp3+ and Foxp3 cells in steady-state conditions may not
reflect the probability of new Foxp3 induction in individual T cells,
especially when T cells are expanding and dying during the immune
response. Furthermore, human studies show that the level of Foxp3
expression may determine the functional state of Treg: the higher
Foxp3 expression is, the more suppressive Treg are (Miyara et al,
2009; Fujii et al, 2016). Thus, it is fundamental to investigate the
temporal dynamics of Foxp3 transcription over time in individual T
cells in vivo, but this has been technically difficult to do to date.
Here, we use our novel Timer of cell kinetics and activity
(Tocky) system to reveal the time and frequency of Foxp3 transcrip-
tion during peripheral immune responses (Bending et al, 2018). In
the Foxp3-Tocky system, the transcriptional activity of the Foxp3
gene is reported by Fluorescent Timer protein, the emission spec-
trum of which spontaneously changes from Blue to Red fluorescence
after translation (Subach et al, 2009). We show that during
inflammation, the flux of Foxp3 to Foxp3+ T cells dramatically
increases within the periphery. In addition, we demonstrate that the
real-time frequency of Foxp3 transcription determines effector Treg
differentiation. Thus, we provide experimental evidence that Foxp3
expression is dynamically regulated in Treg and non-Treg during
inflammation in vivo, providing fresh insight into Foxp3-driven
T-cell regulation.
Results
Timer-Blue fluorescence reports real-time Foxp3 transcription
Fluorescent Timer protein (Timer) is an mCherry mutant (precisely
FT-Fast), and when translated, the chromophore of Timer is an unsta-
ble blue form, which spontaneously and irreversibly matures to
become a stable red form (Subach et al, 2009). We hypothesised that
Timer-Blue fluorescence in Foxp3-Tocky mice reports the real-time
transcriptional activities of the Foxp3 gene. To determine the relation-
ships between Timer mRNA expression and endogenous Foxp3 tran-
scripts, we performed an RNA degradation assay using actinomycin
D. After actinomycin D treatment, the transcripts of Timer, Foxp3 and
an unrelated mRNA species, Hprt, exhibited similar half-lives (1.14,
1.46 and 1.73 h, respectively, Fig 1A). This indicates that Timer tran-
scripts are well correlated to Foxp3 ones in Foxp3-Tocky T cells, in
which Timer transcripts report the transcriptional activity of the Foxp3
gene (Bending et al, 2018). Next, we analysed the half-life of Timer-
Blue fluorescence in activated T cells in vitro using a short-term treat-
ment with cycloheximide (CHX) to inhibit new protein synthesis.
While a previous study estimated the maturation half-life of Timer-
Blue to be 7.1 h, using purified Timer proteins and by fitting data to a
pharmacological kinetic model (Subach et al, 2009), here we aimed to
experimentally determine the half-life of Timer-Blue fluorescence by
flow cytometric analysis of Foxp3-Tocky T cells. Upon CHX treatment,
flow cytometric plots showed that Foxp3-Timer-Blue fluorescence
rapidly decayed, while Timer-Red fluorescence was more stable
(Fig 1B). The half-life of Timer-Blue fluorescence was estimated to be
4.1 h (Fig 1C), which was in keeping with measurements of Timer-
Blue using the Nr4a3-Tocky system (Bending et al, 2018). In contrast,
Timer-Red fluorescence gradually increased (Fig 1D), due to the accu-
mulation of matured proteins. In addition, we investigated the decay
of Timer-Red fluorescence by sorting pure Timer-Red+ T cells from
Nr4a3-Tocky mice (Bending et al, 2018), in which Timer-Blue
proteins are only induced in response to TCR stimulation, and
cultured them in the absence of TCR stimuli (Fig 1E). These data
showed that Timer-Red fluorescence was relatively long-lived and
decayed with a half-life of approximately 122 h (Fig 1F). The short
half-life of Timer-Blue fluorescence indicates that Timer-Blue fluores-
cence reports real-time Foxp3 transcripts, while Timer-Red fluores-
cence captures the cumulative activity of Foxp3 transcription over a
period of 5 days.
Thymic CD4-single-positive cells have higher rates of new Foxp3
transcription compared to splenic CD4+ T cells in neonatal mice
In neonatal mice, Foxp3+ T cells are actively produced in the
thymus (Dujardin et al, 2004). In Foxp3-Tocky mice, thymic CD4-
single-positive cells showed a higher percentage of Blue+ cells in
Timer+ cells than splenic CD4+ cells (i.e. 95 and 63% of all Timer+
cells were Blue+, Fig 2A).
Timer fluorescence data can be quantitatively analysed by the
Timer data analysis for the Tocky system (Bending et al, 2018).
Briefly, Timer fluorescence data are subjected to data pre-processing,
including thresholding and Blue-Red normalisation, and subse-
quently transformed by a trigonometric function to calculate the
angle from the Blue axis (Timer-Angle) in the Blue-Red plane
(Bending et al, 2018; i.e. to use the polar coordination; Fig 2B).
Since the maturation of Timer proteins is unidirectional from Blue to
Red, Timer expression starts from Blue+Red (the New locus), these
New cells mature and acquire Red fluorescence within 4 h (Fig 1C
and D). When Timer transcription persists, cells eventually reach a
balanced steady state for Blue and Red fluorescence and accumulate
in Blue+Red+ Persistent locus around 45° degree from the normalised
Blue axis. When Timer transcription is arrested, cells lose Blue fluo-
rescence and stay in the BlueRed+ Arrested locus while Red
proteins decay with half-life of 5 days (Fig 1F). Cells in the Arrested
locus can however immediately acquire Blue fluorescence again
when they re-initiate Foxp3 transcription (Fig 2B), indicating that the
Timer-Angle between Persistent–Arrested loci represents the recent
frequency of Foxp3 transcriptional activity (Bending et al, 2018).
Timer-Blue expression levels in Timer+ cells were much higher in
the thymus than in the spleen, while Timer-Red expression levels
were higher in the spleen (Fig 2C). These data indicate that the rate
of Foxp3 transcription is higher in the thymus than the spleen, while
splenic Foxp3+ cells have transcribed the Foxp3 gene for a longer
time on average than thymic Foxp3+ cells. These results thus
further confirm that Foxp3-Tocky captures real-time Foxp3 transcrip-
tion by Timer-Blue fluorescence and its history and cumulative
activity by Timer-Red in vivo. The mean Timer-Angle of 10-day-old
(D10) neonatal thymus is ~25°, while that of the age-matched spleen
is ~75°, indicating that the thymus is enriched with the T cells that
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have recently initiated Foxp3 transcription (Fig 2D). Timer locus
analysis showed that splenic Treg remarkably accumulated cells in
the PAt and Arrested loci, indicating that the majority of spleen Treg
have less frequent transcription than thymic Treg. Interestingly, the
frequency of T cells in the New locus (i.e. T cells that have newly
transcribed the Foxp3 gene in the previous ~4 h) is not much
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Figure 1. Timer-Blue fluorescence reports real-time Foxp3 transcription.
A CD4+ T cells from Foxp3-Tocky mice were cultured for the indicated time points with 10 lg/ml actinomycin D. RNA was extracted and Timer, Foxp3 and Hprt mRNA
detected by RT-PCR. Plotted are the raw Ct values, showing culture triplicates (n = 3). Data were reproduced in two independent experiments.
B Naïve T cells from Foxp3-Tocky mice were stimulated for 48 h in the presence of anti-CD3 and anti-CD28 in the presence of IL-2 and TGFb. After 48 h, cells were
harvested and incubated with 100 lg/ml cycloheximide for the indicated time points. Cells were analysed by flow cytometry, and shown is the Timer-Blue versus
Timer-Red fluorescence within CD4+ T cells.
C, D Summary data of % Timer-Blue+ or % Timer-Red+ in the cultures following addition of cycloheximide. Linear regression analysis by Pearson’s correlation. Data
showing culture triplicates (n = 3) were reproduced in two independent experiments.
E BlueRed+ CD4+ T cells from Nr4a3-Tocky mice were cultured for the indicated time points and then analysed by histograms for Timer-Red fluorescence in live cells.
F Linear regression analysis by Pearson’s correlation of decay of Timer-Red Mean fluorescence intensity (MFI) in cultures. Data showing culture triplicates (n = 3)
were reproduced in two independent experiments.
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different between the thymus and the spleen from D10 neonates and
is ~0.7 and ~0.4% on average, respectively (Fig 2E).
The flux of new Foxp3 expressors and the rate of Foxp3
transcription are increased in tissue-infiltrating T cells during
the immune response
Next, we tested whether Foxp3 transcriptional activity is dynami-
cally regulated during the immune response. We used a skin
contact hypersensitivity (CHS) model to analyse the dynamics of
Foxp3 transcription in draining lymph nodes (dLN) and skin-infil-
trating T cells after sensitising mice with the hapten oxazolone and
challenging them on their ears (Fig 3A). While the effect of hapten
on the Timer expression in T cells from dLN showed only marginal
changes in the first 5 days during the sensitisation phase (Fig 3B
and C), it became more remarkable in the challenge phase.
Notably, skin-infiltrating T cells from oxazolone-treated skin had
high Timer-Blue expression with lower Timer-Angle values (Fig 3D
and E). The distribution (precisely, kernel-density estimation, i.e. a
smoothed version of histogram) of Timer-Angle values was mark-
edly right-skewed in dLN, whether vehicle- or oxazolone-treated,
while the Timer-Angle distribution in the skin showed peaks
around 30° to 60° (Fig 3E). T cells were not present in sufficient
numbers to be recovered from vehicle-treated control skin. Most
Timer+ cells in dLN were Red+, and these expressed various
levels of Blue fluorescence (Fig 3B), which indicates that Foxp3
transcription levels vary between individual cells. While immuni-
sation with oxazolone resulted in significant increases in Foxp3
transcription, as evidenced by increase in Timer-Blue and a
concomitant reduction in Timer-Angle, in dLN, skin-infiltrating T
cells showed uniformly high Timer-Blue fluorescence, indicating
that these cells had high-frequency persistent Foxp3 transcription
(Fig 3D and F). On the other hand, Timer-Red fluorescence was
lower in skin-infiltrating T cells than dLN cells (Fig 3G), and
thus, Timer-Angle was the lowest in skin-infiltrating T cells
(Fig 3H). These indicate that these skin T cells had less accumu-
lated Foxp3 transcripts and thus that these cells are short-lived
or rapidly dividing.
Furthermore, we classified cells according to Timer-Angle: New
(Angle = 0), Persistent (Angle 30°–60°) and Arrested (Angle = 90°).
The areas between New and Persistent and between Persistent and
Arrested are designated as NPt and PAt, respectively (Bending et al,
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Figure 2. Thymic CD4-single-positive cells have higher rates of new Foxp3 transcription compared to splenic CD4+ T cells in neonatal mice.
A CD4-single-positive cells from the thymus and CD4+ T cells from the spleens of day 10-old Foxp3-Tocky mice were analysed for Timer-Blue versus Timer-Red
expression by flow cytometry.
B Timer data analysis schematic (for detailed methodology see Bending et al, 2018).
C Summary data of Timer-Blue and Timer-Red MFI of CD4+ T cells from thymus or spleen of individual Foxp3-Tocky mice, n = 5, error bars represent mean  SD.
D Summary data of Timer-Angle in CD4+ T cells from thymus or spleen of individual Foxp3-Tocky mice, n = 5, error bars represent mean  SD.
E Timer locus analysis of CD4+ T cells from thymus or spleen of individual Foxp3-Tocky mice, n = 5, error bars represent mean  SD.
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2018; Fig 2B). This Timer locus analysis clearly showed that skin-
infiltrating T cells were enriched with New, NPt and Persistent cells,
compared to dLN T cells (Fig 3I). Collectively, these results indicate
that flux from Foxp3 to Foxp3+ T cells is increased at sites of
inflammation and that skin-infiltrating Foxp3+ T cells have more
active Foxp3 transcription and are short-lived. These cells are
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enriched with newly born cells, which may be undergoing cell divi-
sion and/or accelerated cell death.
Foxp3 autoregulation maintains the temporal dynamics of
persistent Foxp3 transcription
The dynamic regulation of Foxp3 transcription during the immune
response led us to hypothesise that Foxp3 protein itself is involved
in the regulation of Foxp3 transcription. In order to understand the
mechanism regulating temporally dynamic Foxp3 transcription, we
addressed this possibility by investigating the dynamics of Foxp3
transcription in the absence of Foxp3 protein. To achieve this, we
crossed Foxp3-Tocky mice with Foxp3EGFP/Scurfy mice. Treg from
females from this line will all express the Foxp3-driven Timer
protein, but half will express Foxp3/EGFP and the other half (EGFP-
negative) express the non-functional Scurfy Foxp3 mutant protein
(Fig 4A) due to random X-inactivation (Gavin et al, 2007; Lin et al,
2007). This triple transgenic system thus permits the analysis of
Foxp3 transcriptional activity in the absence of functional Foxp3
protein. Foxp3-Tocky Foxp3EGFP/Scurfy female mice were immunised
with oxazolone, and subsequently, Foxp3 expression within the dLN
was analysed. As scurfy T cells are rare, this was performed during
the sensitisation phase in order to analyse a larger number of lymph
nodes. All Timer+ T cells were analysed and divided into GFP+ (WT
Foxp3) or GFP (Scurfy Foxp3 mutant) expressing Treg. Interest-
ingly, the majority of Timer+ cells were Blue+ in WT Foxp3 cells,
while the majority of Timer+ cells were Blue in Scurfy cells
(Fig 4B). Timer-Blue levels were remarkably decreased, and Timer-
Red levels were also moderately decreased, in Scurfy cells (Fig 4C).
Timer-Angle was significantly higher and approached 90° in Scurfy
cells (Fig 4D). Scurfy Timer+ cells had very few cells displaying
Persistent or PAt transcriptional dynamics compared to GFP+ Treg,
with nearly all cells located in the Arrested locus (Fig 4E). Further-
more, in the absence of Foxp3 protein, Timer-expressing Persistent/
PAt cells actively transcribed Il2 (Fig 4F), a characteristic of antigen-
stimulated effector T cells. These findings reveal that Foxp3 protein
is itself required for controlling Foxp3 transcription, and the Foxp3
autoregulatory loop actively operates in reactive Treg, suppressing
their effector function.
Persistent Foxp3 transcription promotes the effector
Treg programme
These results suggest that persistent Foxp3 transcription defines
Treg with a unique functional status. In order to address this
hypothesis, we analysed the influence of Foxp3 transcription status
on transcriptional profile using RNA-seq. To our knowledge,
currently, no flow cytometer is equipped with the function to use
derivative parameters, and it is not possible to sort cells according
to Timer-Angle. We sorted cells, therefore, according to their posi-
tions in the Blue-Red plane and experimentally confirmed that
distinct Timer populations were sorted according to Timer-Angle.
T cells were isolated from mice immunised with oxazolone and
sorted into four populations by flow cytometry based on their
Timer-Blue and Timer-Red expression pattern: “Persistent” Foxp3
transcriptional expressors were isolated as Pers1 (Blue-inter-
mediate Red-low) and Pers2 (Blue-high Red-high), in addition to
PAt (Blue-low Red-high) and Arrested (Blue-negative Red-inter-
mediate) Foxp3 expressors. Sorted cells were analysed by flow
cytometry to confirm the purity according to the gate (Fig 5A).
Timer analysis showed that each population exhibited discrete
Timer-Blue, Timer-Red and Timer-Angle values (Fig 5B–D), con-
firming the successful flow sorting of the four distinct populations,
the mean angles of which corresponded to the desired loci. Princi-
pal component analysis (PCA) showed that the persistent Foxp3
expressors (i.e. Pers1 and Pers2) were clustered and similar to
each other, and distinct from PAt and Arrested Foxp3 expressors,
which made another cluster (Fig 5E). Differential expression anal-
ysis identified unique clusters of genes (Fig 5F). Persistent Foxp3
expressors highly expressed the coinhibitory/costimulatory mole-
cules Ctla4, Icos and Tigit, and the serine protease Gzmb, all of
which are involved in cancer immunity (Sharma et al, 2017). In
addition, persistent Foxp3 expressors transcribed other effector
Treg signature genes such as Nkg7, Fgl2 and Irf4, while they had
low expression of naı¨ve T-cell-specific genes such as Ccr7, Bach2
and Il7r. These features are fully compatible with the previously
reported effector Treg phenotype (Rosenblum et al, 2016; Wyss
et al, 2016). The specific increase in the activation gene Mki67
(Ki67) in persistent Foxp3 expressors also supports the idea that
these cells are highly activated and dividing. Intriguingly, Pearson
correlation analysis showed that Ctla4 and effector Treg markers
(Icos, Lag3, Tigit, Ccr4) had relatively low correlation to Foxp3
levels (R2 was between 0.30 and 0.65; Fig EV1A), while these
markers showed very high correlation to the activation gene,
Mki67 (R2 was between 0.90 and 0.98; Fig EV1B). This suggests
that the T-cell activation process predominantly regulates these
markers and that persistent Foxp3 expressors express these
markers because they are highly activated. In contrast, Tnfrsf18
(GITR) and Tnfrsf4 (OX40) showed high correlations to Foxp3
(R2 = 0.91 and 0.82, respectively), but only moderate correlations
▸Figure 3. The flux of new Foxp3 expressors and the rate of Foxp3 transcription are increased in tissue-infiltrating T cells during the immune response.A Schematic displaying experimental set-up for analysis of sensitisation and challenge phases of oxazolone-induced CHS using Foxp3-Tocky mice.
B Analysis of Timer-Blue versus Timer-Red fluorescence in CD4+ T cells from Foxp3-Tocky mice 5 days after sensitisation with oxazolone or vehicle control.
C Kernel-density distributions of Timer-Angle values from (B).
D 48 h after challenge with oxazolone or vehicle control, CD4+ T cells from Foxp3-Tocky mice were analysed. Displayed are Timer-Blue versus Timer-Red flow
cytometry plots from vehicle or oxazolone dLN or ear skin.
E Kernel-density distributions of Timer-Angle values from (D).
F–H Summary of data showing mean Timer-Blue (F) or Timer-Red intensity (G) or Timer-Angle values (H) in Timer+ T cells in vehicle dLN (n = 9), oxazolone dLN
(n = 11) or skin (n = 12), 24–48 h after ear challenge of mice with oxazolone, error bars represent mean  SD. *P < 0.05, **P < 0.01, ***P < 0.001. Statistical
analysis by one-way ANOVA with Tukey’s honest significant difference test.
I Timer locus analysis of CD4+ T cells from vehicle dLN (n = 9), oxazolone dLN (n = 11) or skin (n = 12), 24–48 h after ear challenge of mice with oxazolone, error
bars represent mean  SD. **P < 0.01, ***P < 0.001. Statistical analysis by one-way ANOVA with Tukey’s honest significant difference test.
Data information: Data are pooled from four independent experiments.
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to Mki67 (R2 = 0.49 and 0.74, respectively), suggesting that
Foxp3 may more closely regulate GITR and OX40. Il2ra is ubiqui-
tously highly expressed by all Foxp3+ cells, and not by Foxp3
cells, and showed only low correlations to both Foxp3 and Mki67
levels (R2 = 0.26 and 0.43), suggesting that CD25 expression is
stabilised in Foxp3+ cells but regulated primarily by other
factors, such as IL-2 signalling once Foxp3 is expressed
(Fig EV1A and B). Persistent Foxp3 expressor-specific genes were
enriched with cell cycle-related pathways. In contrast, the PAt
and Arrested-specific genes were enriched with cytokine signal-
ling pathways but not cell cycle-related pathways (Fig 5G).
Collectively, RNA-seq analyses showed that temporally persistent
Foxp3 transcription is an underlying mechanism for effector Treg
differentiation.
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Figure 4. Foxp3 autoregulation maintains the temporal dynamics of persistent Foxp3 transcription.
A Design of Foxp3-Tocky:Foxp3EGFP/Scurfy triple transgenic system to analyse the role of functional Foxp3 in regulation of Foxp3 transcription. Foxp3-Tocky Foxp3EGFP/Scurfy
female mice were sensitised with oxazolone for 5 d before analysis of superficial LN (sLN).
B Shown is Timer-Blue versus Timer-Red expression on Timer+ T cells within GFP+ (i.e. WT) or GFP (i.e. scurfy) T cells.
C Timer-Blue and Timer-Red MFI in Timer+ T cells from GFP or scurfy expressing Treg. Bars represent mean  SD, statistical analysis by Student’s t-test. *P < 0.05,
****P < 0.0001.
D Mean Timer-Angle values of Foxp3EGFP and Foxp3Scurfy cells, n = 4. Bars represent mean  SD, statistical analysis by Student’s t-test. ***P < 0.001.
E Proportion of Timer+ cells within the five Timer loci in Foxp3EGFP and Foxp3Scurfy from sLN (n = 4 mice). Bars represent mean  SD, statistical analysis by Kruskal–
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F qPCR for Il2 mRNA in Naïve, CD44hi effector T cells (Teff) and Foxp3 Persistent cells (Blue+Red+) from GFP+ (Foxp3EGFP) and GFP (Foxp3Scurfy). Cells were sorted and
RNA was extracted for qPCR, n = 4. Bars represent mean  SD. Data combined from two experiments. Statistical analysis of log10 mRNA expression values by one-
way ANOVA with Tukey’s honest significant difference test. *P < 0.05, ****P < 0.0001.
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Identification of distinct groupings of cell surface markers for
targeting T cells with specific Foxp3 transcriptional dynamics
Next, we analysed protein expression of candidate surface proteins
identified by RNA-seq for targeting T cells with specific Foxp3 tran-
scriptional dynamics in vivo. T cells from Foxp3-Tocky mice were
immunised with oxazolone and analysed by flow cytometry for the
expression levels of candidate markers from Fig 5 in each Timer
locus. Hierarchical clustering of MFI levels showed that these candi-
date genes were grouped into two main groups, in addition to
Neuropilin 1 (Nrp1) which had its own separate cluster (Fig 6A).
Group I markers showed high expression throughout New–Persis-
tent Foxp3 expressors, but fell drastically as Blue fluorescence
decreases in PAt and Arrested Foxp3 expressors (Fig 6B), suggesting
that these markers are associated with the initiation of new Foxp3
transcription in activated T cells and with high-frequency Foxp3
transcription. Group II markers are less expressed in new Foxp3
expressors, and increased in persistent and PAt Foxp3 expressors
(Fig 6C), suggesting that these markers can be sustained by moder-
ate frequencies of Foxp3 transcription once the Foxp3 autoregula-
tory loop is established. Nrp1 is characteristically high in PAt Foxp3
expressors, which may explain why this marker has been used to
identify thymus-derived Treg (Fig 6D). Importantly, the expression
levels of both Group I and II markers markedly declined in Arrested
Foxp3 expressors. Together, these results further support the notion
that the temporal frequency (rate) of Foxp3 transcription regulates
the Treg phenotype and function.
Foxp3-Tocky allows visualisation of the manipulation of
T cells with specific Foxp3 transcriptional dynamics
upon immunotherapy
We asked whether surface proteins from Group I and Group II in
Fig 6 can be used to target T cells with specific Foxp3 transcriptional
dynamics. If successful, this approach may lead to future precision
immunotherapy for controlling Foxp3-mediated immune regulation
by manipulating its temporal dynamics. Both TNFRII (Group I) and
OX40 (Group II) are targets for immunotherapy and may be used to
manipulate T-cell responses, and currently, clinical trials are ongo-
ing for melanoma and other solid cancers (Croft et al, 2009).
However, it is unknown whether these immunotherapy antibodies
affect Foxp3 transcriptional dynamics.
Using the CHS model, antibodies were administered during the
challenge phase (Fig 7A). Treatment with anti-TNFRII antibody
increased the frequency of Blue+Red T cells and Blue+Red+ T cells
at the inflamed site (Fig 7B). Although average Blue and Red levels
were overall not affected by the antibody (Fig 7C and D), Timer-
Angle tended to be lower within the anti-TNFRII-treated group
(P = 0.055), likely reflecting the increased proportion of pure blue T
cells at the inflamed site (Fig 7E). Analysis of the Timer-Angle
distribution revealed that isotype control treatment showed one
dominant peak around the 45° mark, while anti-TNFRII treatment
produced a more flattened, peak from 25 to 50 degrees (Fig 7F).
Analysis of Timer locus revealed that anti-TNFRII increased both
New and NPt stage Foxp3 expressors, indicating that anti-TNFRII
immunotherapy may enhance the flux of Foxp3 into Foxp3+ T
cells (Fig 7G). There was no significant change in the high-
frequency/persistent Foxp3 transcribers, and anti-TNFRII treatment
did not significantly alter the course of inflammation (Fig 7H). In
contrast, anti-OX40 treatment reduced the frequency of Blue+Red+
Foxp3+ T cells in inflamed skin (Fig 7I). While Blue levels were
unaffected (Fig 7J), both Timer-Red and Timer-Angle were signifi-
cantly lower in anti-OX40-treated mice (Fig 7K and L). Interestingly,
the peak of Timer-Angle distribution in anti-OX40-treated mice was
shifted towards the NPt (Fig 7M). Timer locus analysis revealed
that anti-OX40 reduced the frequency of more mature Foxp3 expres-
sors, as both Persistent and PAt loci were significantly reduced in
anti-OX40-treated mice (Fig 7N). These data indicate that, in the
presence of anti-OX40 antibody, Treg are very short-lived at the
inflamed site and that a proportion of high-frequency Foxp3 expres-
sors are either depleted or undergo activation-induced death. In
fact, a majority of skin-infiltrating OX40+ T cells were stained by
Annexin V while OX40 counterparts were not (Fig EV2). Interest-
ingly, anti-OX40 treatment delayed the resolution of inflammation
(Fig 7O). These data together suggest that effector Treg in the skin
are pre-apoptotic-activated cells that function as suppressor cells
and that anti-OX40 antibody accelerated the death of pre-apoptotic-
activated Foxp3+ T cells by the mechanism of activation-induced
cell death. In summary, both of the effects of the immunotherapies
tested were in keeping with the Foxp3 transcriptional dynamics
identified in Fig 6, showing how Foxp3-Tocky may be used to iden-
tify new therapeutic targets and mechanism of drug action in pre-
clinical models.
Discussion
Sustained Foxp3 transcription is a cardinal feature of the functional
maturation of Treg (i.e. effector Treg) (Fig 5). Importantly, sustained
Foxp3 transcription requires functional Foxp3 protein itself. This
type of transcriptional regulation (i.e. transcription factor regulates
its own gene) is defined as positive autoregulation, which allows a
◀ Figure 5. Persistent Foxp3 transcription promotes the effector Treg programme.A Foxp3-Tocky mice were sensitised with oxazolone for 5 days and dLN harvested and stained with CD4 and CD44 for sorting. Pre- and post-sort purities displaying
Timer-Blue versus Timer-Red fluorescence for Tnaive (CD4+CD44loTimer) and Teff (CD4+CD44hiTimer). Timer+ T cells from sensitised Foxp3-Tocky mice were
sorted into Pers1, Pers2 PAt and Arrested T cell subsets, according to the maturation of Timer chromophore. A small proportion of sorted cells were analysed by
flow cytometry. Red gate indicates the one used for sorting each population, and red number indicates the purity in terms of Timer fluorescence. n = 3 groups,
each made from pools of three mice.
B–D Mean Timer-Blue, Timer-Red fluorescence intensity levels or Timer-Angle in the sorted Timer+ subsets, n = 3. Bars represent mean  SD.
E RNA was extracted from the samples, and sequencing was performed as described in the methods. Cluster analysis of the transcriptomes of the sorted samples by
PCA.
F Heatmap analysis of differentially expressed genes (DEGs) in the four Timer+ subsets, compared to Tnaive and Teff, grouping genes into seven categories.
G Pathway analysis of the four DEG gene lists.
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Figure 6. Identification of distinct groupings of cell surface markers for targeting T cells with specific Foxp3 transcriptional dynamics.
A Foxp3-Tocky mice were sensitised with oxazolone for 4 days, and then, dLN were harvested and CD4+ T cells analysed for Timer expression and key membrane
proteins identified as differentially expressed by RNA-seq. Heatmap analysis of the expression of different surface proteins according to cells within different Timer
loci. These findings generate three main groups.
B–D MFI expression levels of Group I, Group II or Group III surface markers in relation to Timer loci of the cells, n = 4. Bars represent mean  SD.
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slow and sustained transcriptional response to external signalling
cues (Yosef & Regev, 2011). This may constitute the mechanism
behind effector Treg differentiation in inflammatory environments.
It is known that, among the conserved non-coding DNA sequence
(CNS) elements of the Foxp3 gene, the CNS2, which contains the
TSDR, is required for maintenance of Foxp3 expression after cell
division (Zheng et al, 2010). The CNS2 regions are bound by Foxp3
(Zheng et al, 2010), Runx1/Cbf-b (Kitoh et al, 2009; Rudra et al,
2009) and Stat5 (Yao et al, 2007). Intriguingly, the genetic deletion
of CNS2 or Cbf-b results in the reduction in Foxp3 expression in
Treg, especially in activated Treg, and the development of autoim-
mune inflammation (Kitoh et al, 2009; Feng et al, 2014). These
suggest that the autoregulatory circuit of the Foxp3 gene is mediated
through the Foxp3-Runx1 interaction (Ono et al, 2007) at the CNS2
(Rudra et al, 2009), and persistent Foxp3 transcription in activated
Treg is essential for establishing the effector Treg programme and
maintaining immunological tolerance. Given that the autoregulatory
transcriptional circuit sustains Foxp3 transcription, genes with linear
correlations to Foxp3 transcripts (e.g. Tnfrsf4 and Tnfrsf18, Fig EV1)
are likely regulated by this transcriptional circuit. On the other
hand, genes with high expression in persistent Foxp3 expressors that
show moderate correlations to Foxp3 levels (e.g. Ctla4, Fig EV1A)
are likely to be regulated by both the T-cell activation process and
Foxp3 autoregulation-dependent mechanisms. Thus, in activated
effector Treg, the autoregulatory loop of the Foxp3 gene and the T-
cell activation process may cooperatively control transcellular
suppressive mechanisms (e.g. CTLA-4), while suppressing the
effector functions (e.g. cytokine production) in a cell-intrinsic
manner. A future study may focus on the identification of molecular
mechanisms for the establishment and control of the Foxp3 auto-
regulatory transcriptional circuit across chromatin regions and/or at
the single cell level.
Interestingly, the induction of new Foxp3 expression may be
more frequent in physiological conditions than previously
thought. As the half-life of Blue fluorescence is very short, in
young mice, peripherally induced Foxp3 expression may occur in
significant part of CD4+ T cells (up to 0.3% per 4 h, based on
Day 10 New cells in spleen), and these Foxp3+ cells can accumu-
late rapidly unless they die or terminate Foxp3 expression. In the
hapten model, ~10% of Timer+ cells are identified at the New
locus in the skin (Fig 3I). Given that these new Foxp3 expressors
quickly move to NPt/Persistent locus within 4 h (Fig 1B), a signif-
icant proportion of cells at the Persistent locus may have been
supplied from these newly generated Treg before the analysis. It
is also likely that cells at the PAt and Arrested loci move to the
Persistent locus by increasing Foxp3 transcription. Since 1–5% of
Foxp3-CD4+ T cells acquire new Foxp3 expression per 4 h
(Figs 1C, 3I, and 7G and N), these new Foxp3 expressors may be
short-lived. These two possibilities are not mutually exclusive and
are compatible with evidence that the effector Treg population
arises from both thymic and peripherally induced Treg (Rosenblum
et al, 2016), while it is predicted that the ratio of the contributions
may vary between antigens and between individuals (Ono &
Tanaka, 2016).
Intriguingly, the majority of mature Foxp3 expressors in the
inflamed skin are OX40high and Annexin V+. While Annexin V is
often considered as a marker of apoptotic cells, Annexin V+ acti-
vated T cells are still alive and can be functional to preclude the
development of T-cell memory (Wang et al, 2004). Effector Treg in
the inflamed tissue may be in fact such functional pre-apoptotic
cells. Thus, our study supports the model that tissue-infiltrating
effector Treg are actively generated from activated T cells during
inflammation through the autoregulatory transcriptional circuit of
the Foxp3 gene. Most probably, due to their sustained Foxp3 expres-
sion, these cells may function as pre-apoptotic decoy cells that
consume cytokines and thereby suppress the activities of other T
cells until they die. This model is also compatible with the pro-
apoptotic role of Foxp3 under cytokine deprivation (Tai et al,
2013), which may be important for shrinking the expanded Treg
population during the resolution phase of inflammation. These
context-dependent mechanisms of Foxp3 function in T cells may
underlie the pleiotropic mechanisms of anti-OX40: OX40 costimula-
tion enhances the survival of Foxp3 effector T cells (Croft et al,
2009), while it may rather accelerate the death of Foxp3+ effector
Treg.
It may be important to emphasise that the proliferated Treg
will die after resolution of inflammation, as other T cells do
(McKinstry et al, 2010). If some of the reactive Foxp3 expressors
▸Figure 7. Foxp3-Tocky allows visualisation of the manipulation of T cells with specific Foxp3 transcriptional dynamics upon immunotherapy.A Experimental design for the administration of anti-OX40 or anti-TNFRII antibody to target the challenge phase of CHS.
B Mice were challenged with oxazolone and then administered isotype or anti-TNFRII antibodies. 96 h later, CD4+ T cells from the skin were analysed for expression
of Timer-Blue versus Timer-Red (concatenated plots are shown).
C–E Summary of Timer-Blue MFI, Timer-Red MFI or Timer-Angle in skin-infiltrating Timer+ T cells, isotype n = 5, anti-TNFRII n = 3. Bars represent mean  SD.
F Kernel-density distributions of Timer+ T cells in isotype or anti-TNFRII treated mice 96 h after challenge with oxazolone.
G Timer locus distribution of skin-infiltrating CD4+ T cells in isotype or anti-TNFRII-treated Foxp3-Tocky mice. Bars represent mean  SD. Statistical analysis by one-
way ANOVA with Tukey’s honest significant difference method. *P < 0.05
H Ear swelling during the challenge phase of CHS in isotype or anti-TNFRII treated Foxp3-Tocky mice, bars represent mean  SEM.
I Mice were challenged with oxazolone and then administered isotype or anti-OX40 antibodies. 96 h later, CD4+ T cells from the skin were analysed for expression of
Timer-Blue versus Timer-Red (concatenated plots are shown).
J–L Summary of Timer-Blue MFI, Timer-Red MFI or Timer-Angle in skin-infiltrating Timer+ T cells, isotype n = 4, anti-OX40 n = 3. Bars represent mean  SD. Statistical
analysis by Student’s t-test. **P < 0.01, ****P < 0.0001.
M Kernel-density distributions of Timer+ T cells in isotype or anti-OX40 treated mice 96 h after challenge with oxazolone.
N Timer locus distribution of skin-infiltrating CD4+ T cells in isotype (n = 4) or anti-OX40 (n = 3)-treated Foxp3-Tocky mice. Bars represent mean  SD. Statistical
analysis by one-way ANOVA with Tukey’s honest significant difference test. **P < 0.01, ****P < 0.0001.
O Ear swelling during the challenge phase of CHS in isotype (n = 19) or anti-OX40 (n = 18)-treated mice. Data are combined from two experiments and show
mean  95% confidence intervals. Statistical analysis of 24-, 48-, 72- and 96-h time points by two-way ANOVA with Sidak’s multiple comparisons test. **P < 0.01,
***P < 0.001.
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survive beyond the resolution of inflammation, such cells will be
memory T cells by definition. Some cells may sustain Foxp3
expression and survive as “memory Treg”, and some others may
lose Foxp3 expression after the resolution of inflammation and
survive as memory-phenotype (memory-like) T cells (Ono &
Tanaka, 2016). Intriguingly, ex-Treg are enriched in the memory-
phenotype T-cell pool and prone to express Foxp3 more readily
than naı¨ve T cells (Zhou et al, 2009; Miyao et al, 2012). Since, in
non-inflammatory conditions, a majority of Foxp3+ T cells are at
the PAt or Arrested loci (Figs 2A and 3B), and these cells are
similar to each other and distinguished from functional effector
Treg at the transcriptome level (Fig 5E), all these non-reactive
Treg cells may be non-functional and constitute a spectrum of
“memory” T cells against self-antigen, together with naturally
arising memory-phenotype T cells. Importantly, both Foxp3+ Treg
and memory-phenotype T cells infrequently and spontaneously
receive “tonic” TCR signals during homeostasis (Bending et al,
2018), which are required for maintaining the size of Treg popu-
lation and Foxp3 expression (Feng et al, 2014; Vahl et al, 2014).
These together support the model that self-reactive T cells may
have fluctuating Foxp3 expression and can be identified as either
Foxp3+ Treg (PAt or Arrested) or memory-phenotype T cells at
different time points. These hypotheses will be best addressed in
future studies using new approaches to combine the Tocky tech-
nology and single cell technologies.
The current study has shown that Foxp3-Tocky is effective in
designing immunotherapy strategies to target a specific phase of
Foxp3 transcriptional dynamics, and also, for visualising alterations
of the dynamics upon immunotherapy. In fact, we successfully
manipulated in vivo Foxp3 dynamics by targeting Timer stage-
specific surface receptors. By targeting Group I (TNFRII) or Group II
(OX40) marker of Foxp3 dynamics (Fig 6), we either increased the
flux of new Foxp3 transcription (anti-TNFRII) or decreased mature
Foxp3 expressors (anti-OX40). While the precise cellular mechanism
is to be determined, anti-OX40 treatment resulted in the loss of
persistent and PAt Foxp3 expressors within the skin, which are
enriched with effector Treg. OX40 is an emerging target for cancer
immunotherapy, and its agonistic antibodies for augmenting the
effector function of T cells are currently tested in clinical trials
(Aspeslagh et al, 2016). It is currently thought that OX40 is
expressed mainly by activated effector T cells and is also constitu-
tively expressed on all Treg (Weinberg et al, 2011). Such OX40 high
expression is found relatively more frequently on persistent Foxp3
expressors compared to Foxp3-negative effector T cells.
In summary, we have dissected the previously hidden dynamics
of Foxp3 transcription that regulate the functions of Treg through
time. In addition, we have shed light on how Foxp3-mediated
molecular mechanisms coordinate T-cell responses in existing Treg
and non-Treg, introducing a new dimension into studies on Foxp3-
driven T-cell regulation.
Materials and Methods
Study design
Sample size for anti-OX40 CHS experiments was estimated based on
a power calculation with alpha = 0.05 and power 80%, which gave
a sample size of 8. For analysis of Foxp3-Tocky Foxp3EGFP/Scurfy
mice, four mice were analysed over two independent experiments
(age 6–10 weeks). For anti-OX40 experiments, a pilot experiment
was performed to obtain estimates for effect size and standard devi-
ation, which yielded an experimental group size of 9. Two indepen-
dent experiments were then performed to test the null hypothesis
that anti-OX40 treatment had no effect on ear swelling at 96 h. The
null hypothesis was rejected in both experiments, with no signifi-
cant inter-experiment variation. Therefore, data from both experi-
ments were pooled for presentation of results. For all other
experiments, a minimum of three animals was used. Where male
and female mice were used in the same study, these were rando-
mised into experimental groups according to sex and age. Similarly,
wild-type littermates from transgenic mice were randomised into
experimental groups for the anti-OX40 experiments. The individual
making the ear measurement was blinded to the treatment group of
the mouse until after the measurement was taken.
Transgenesis and mice
Foxp3-Tocky and Foxp3-Tocky:Foxp3-IRES-GFP transgenic reporter
strains were generated as described (Bending et al, 2018). The triple
transgenic Foxp3-Tocky Foxp3EGFP/Scurfy mice were generated by
crossing Foxp3-Tocky mice with Foxp3tm9(EGFP/cre/ERT2)Ayr/J and
B6.Cg-Foxp3sf/J (Jackson Laboratories, #016961 and #004088,
respectively). All animal experiments were performed in accordance
with local Animal Welfare and Ethical Review Body at Imperial
College London (Imperial) and University College London (UCL),
and all gene recombination experiments were performed under the
risk assessment that was approved by the review board at Imperial
and UCL.
In vitro cultures for determining mRNA half-lives
CD4+ T cells from the spleens of Foxp3-Tocky mice were isolated
by immunomagnetic separation (StemCell Technologies) and
cultured at 4 × 105 cells per well in the presence of 10 lg/ml actino-
mycin D. Cells were isolated at the indicated time points, and RNA
was extracted, and cDNA synthesises as described below.
In vitro cultures for determining Timer-Blue and
Timer-Red half-life
Naı¨ve T cells from Foxp3-Tocky mice were isolated by negative
selection using immunomagnetic selection (StemCell Technologies)
and 2 × 105 cells cultured on anti-CD3 (clone 1452C11, 2 lg/ml)
and anti-CD28 (clone 37.51, 10 lg/ml; both eBioscience)-coated 96-
well plates (Corning) in the presence of 500 U/ml rhIL-2 (Roche)
and 5 ng/ml rhTGFb (R&D) for 48 h in a final volume of 200 ll
RPMI1640 (Sigma) containing 10% FCS and penicillin/streptomycin
(Life Technologies). Cells were harvested then incubated with
100 lg/ml cycloheximide (Sigma) for the indicated time points
before analysis by flow cytometry. For determination of the red
half-life, BlueRed+ CD4+ T cells from Nr4a3-Tocky mice were
isolated by cell sorting and then cultured without TCR signals under
the presence of rhIL-2 for the indicated number of hours before
analysis by flow cytometry. Importantly, IL-2 signals do not induce
Timer expression in Nr4a3-Tocky T cells (Bending et al, 2018).
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Contact hypersensitivity and antibody treatments
Oxazolone (Sigma) solutions were prepared fresh in ethanol for
each experiment. For sensitisation, 150 ll of 3% oxazolone was
applied to the shaven abdominal skin of anaesthetised 5- to 10-
week-old mice. Five days later, left and right ear thickness were
measured, and the elicitation phase started by the application of
20 ll of a 1% oxazolone solution to one ear, or 20 ll of vehicle
(100% ethanol) to the contralateral ear. Twenty-four to 96 h later,
ear thickness was measured using a digital micrometer (Mitutoyo).
In anti-OX40 experiments, 0.5 mg of anti-OX40 (OX86, BioXCell) or
rat IgG1 (MAC221, kind gift from Prof. Anne Cooke) was injected
i.p. on day of challenge and 48 h later. For anti-TNFRII experiments,
0.5 mg of anti-TNFRII (TR75-54.7 BioXCell) or Armenian hamster
IgG (BioXCell) was injected intra-peritoneally (i.p). on day of
challenge.
Flow cytometric analysis and cell sorting
Following spleen or thymus removal, organs were forced through a
70-lm cell strainer to generate a single cell suspension. For spleno-
cyte preparations, a RBC-lysis stage was employed. Ears were
removed and cut into small fragments, which were forced through a
70-lm cell strainer, to make a single cell suspension. Cells were
washed once before re-filtering through a 50-lm cell strainer. Stain-
ing was performed on a V-bottom 96-well plate or in 15-ml falcon
tubes for cell sorting. Analysis was performed on a BD FACS Aria III
(Figs 2–5 and 7) or Fortessa (Figs 1, 6 and EV2) instrument. The
blue form of the Timer protein was detected in the blue (450/
40 nm) channel excited off the 405 nm laser. The red form of Timer
protein was detected in the mCherry (610/20) channel excited off
the 561-nm laser. For all experiments, a fixable eFluor 780-fluores-
cent viability dye was used (eBioscience). The following directly
conjugated antibodies were used in these experiments: CD4 APC
(clone RM4-5, eBioscience), CD4 Alexa Fluor 700, CD4 BUV395
(clone GK1.5 BD Biosciences), (clone RM4-5, BioLegend), CD8 PE-
Cy7 (clone 53-6.7, BioLegend), CD8 BUV737 (clone 53-6.7, BD Bio-
sciences), TCRb FITC & Alexa Fluor 700 (clone H57-597, BioLegend),
TCRb BUV737 (clone H57-597, BD Biosciences), CD25 PerCPcy5.5
(PC61.5, eBioscience) or PE-Cy7 (PC61.5, Tonbo Bioscience), CD44
APC (clone IM7, eBioscience) or Alexa Fluor 700 (clone IM7, BioLe-
gend), OX40 PE-Cy7 and APC (clone OX86, BioLegend), GITR FITC
(clone DTA-1, BioLegend), TNFRII APC (clone TR7554, R&D
Systems), Neuropilin-1 APC or PE-Cy7 (clone 3E12 BioLegend),
CD103 APC (clone 2E7, BioLegend), CCR4 APC (clone 2G12, BioLe-
gend), TIGIT PE-Cy7 (Clone 1G9, BioLegend), CCR2 AF647 (clone
SA203G11, BioLegend), CCR5 APC (clone HM-CCR5, BioLegend)
and Sca1 (clone D7, BioLegend). Annexin V staining was performed
using APC-labelled Annexin V, according to the manufacturer’s
instructions (eBioscience).
qPCR analysis
For sorted cells, RNA was extracted using the Arcturus PicoPure
RNA kit (Life Technologies) according to the manufacturer’s instruc-
tions. cDNA was generated using random hexamers and Superscript
II (Life Technologies) according to the manufacturer’s instructions.
mRNA expression was quantified using SYBR green (BioRad) and
expressed relative to the housekeeping gene Hprt. Primer sequences:
Hprt For: AGCCTAAGATGAGCGCAAGT, Hprt Rev: TTACTAGGCA
GATGGCCACA. Il2 For: AGCAGCTGTTGATGGACCTA Il2 Rev:
CGCAGAGGTCCAAGTTCAT (Martins et al, 2008). Foxp3 For:
CACCCAAGGGCTCAGAACTTCTAG, Foxp3 Rev: ATGACTAGGGG
CACTGTAGGCA, Foxp3-Timer For: CAGCTCCTCTGCCGTTATCC,
Foxp3-Timer Rev: CCTCGCCCTCGATCTCGA
RNA-seq
Foxp3-Tocky mice were sensitised by application of 3% oxazolone
to the abdomen. Five days later, dLN were harvested and
CD44loFoxp3, CD44hiFoxp3, Pers1, Pers2, PAt and Arrested T cells
were sorted and RNA extracted using the Arcturus PicoPure RNA kit
(Life Technologies) according to the manufacturer’s instructions.
Library was prepared using the Illumina TruSeq Stranded mRNA
LT kit according to manufacturer’s instructions. Libraries were anal-
ysed by Bioanalyzer (Agilent) for quality control and quantified
using Qubit (Life Technologies). Library concentrations were
normalised and pooled and sequenced on the Illumina HiSeq
platform (Illumina), and 100-bp paired-end readings were obtained.
After demultiplexing fastq files and performing QC analysis by
fastQC, sequence reads were aligned to either the mouse genome
(mm10) with or without the Timer gene by TopHat2. Statistical
analysis was performed using the Bioconductor package DESeq2.
Differentially expressed gene lists were generated using the union of
the genes with FDR < 0.05 and log fold change > 1 in comparison
with any of the other three sample groups (i.e. Pers1 versus PAt,
Arrested and CD44hi). PCA was performed using the CRAN package
Stats, and the 3D plot was generated by the CRAN package rgl.
Heatmap was generated by the CRAN package gplots, and hierarchi-
cal clustering used a complete linkage algorithm. Pathway analysis
was done using the Bioconductor package clusterProfiler and the
Reactome database through the package ReactomePA.
Timer data analysis
Sample data including a negative control were batch gated for T-cell
populations and exported by FlowJo (FlowJo LLC, OR) into csv files,
including all compensated fluorescence data in the fcs file. The code
developed in this study imports csv files into R, pre-processes and
normalises data, and automatically identifies Timer+ cells and
performs trigonometric data transformation, producing Timer-Angle
and Timer-Intensity data for individual cells in each sample, as
previously described (Bending et al, 2018). Basic procedures for
flow cytometric data analysis have been previously described else-
where (Fujii et al, 2016).
Statistical analysis and data visualisation
Statistical analysis was performed on R or Prism 6 (GraphPad) soft-
ware. Percentage data for Timer+ and Timer locus analysis were
analysed by Mann–Whitney U-test or Kruskal–Wallis test with
Dunn’s multiple comparisons using the CRAN package PMCMR.
Samples with fewer than 20 Timer+ cells were not included in the
analysis (except for Fig 7G, where threshold was set as 10). For
analysis of mRNA, ear thickness data, and Timer-Angle and inten-
sity, Student’s t-test was used for comparison of two means. For
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comparison of more than two means, a one-way ANOVA with
Tukey’s post hoc test was applied using the CRAN package Stats.
For comparison of variation between two data sets across two vari-
ables, a two-way ANOVA was used with Sidak’s multiple compar-
isons test. Scatter plots and density plots were produced by the
CRAN packages ggplot2 and graphics. All computations were
performed on Mac (version 10.11.6). Adobe Illustrator (CS5) was
used for compiling figures and designing schematic figures. Vari-
ance is reported as SD or SEM unless otherwise stated. *P < 0.05,
**P < 0.01, ***P < 0.001, ****P < 0.0001.
Data and code availability
RNA-seq data can be obtained at NCBI GEO with the accession
number GSE89481. All R codes are available upon request. Data will
be made available upon reasonable requests to the corresponding
author.
Expanded View for this article is available online.
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